Josephin-1 Activators

Josephin-1, also known as Ataxin-3, is a deubiquitinating enzyme encoded by the ATXN3 gene, which is implicated in the ubiquitin-proteasome system, a crucial pathway for protein degradation and turnover within the cell. The protein's most notable feature is its role in the pathogenesis of Machado-Joseph Disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), which is a neurodegenerative disorder.Josephin-1 has a catalytic domain that possesses deubiquitinating activity, enabling it to cleave ubiquitin chains from ubiquitinated proteins. This activity is critical for maintaining cellular homeostasis by regulating the degradation of proteins, thereby preventing the accumulation of misfolded or damaged proteins that can lead to cellular dysfunction.

The Josephin domain, which is the active site of the enzyme, confers specificity for ubiquitin chains, particularly linked through lysine 48 and lysine 63 residues of ubiquitin. Josephin-1 interacts with various partners within the ubiquitin-proteasome pathway and is thought to be involved in the editing of ubiquitin chains, which dictates the fate of proteins marked for degradation or other cellular processes.Mutations within the ATXN3 gene, specifically an expanded CAG trinucleotide repeat encoding an elongated polyglutamine (polyQ) tract in the protein, lead to the development of MJD. The expanded polyQ tract in Josephin-1 causes the protein to aggregate, forming neuronal intranuclear inclusions that are toxic to cells, particularly affecting the cerebellum and brainstem, leading to the progressive coordination and movement impairments seen in MJD.